Home LiteratureArticle Details
PMID: 12415308 Published · ppublish English Journal Article Review

The immunology of susceptibility and resistance to Leishmania major in mice.

Nature reviews. Immunology ·Vol. 2 ·No. 11 ·2002-11-00 ·Pages 845-58

Sacks D, Noben-Trauth N

Abstract

Established models of T-helper-2-cell dominance in BALB/c mice infected with Leishmania major -- involving the early production of interleukin-4 by a small subset of Leishmania-specific CD4+ T cells -- have been refined by accumulating evidence that this response is not sufficient and, under some circumstances, not required to promote susceptibility. In addition, more recent studies in L. major-resistant mice have revealed complexities in the mechanisms responsible for acquired immunity, which necessitate the redesign of vaccines against Leishmania and other pathogens that require sustained cell-mediated immune responses.

MeSH Terms
Animals CD8-Positive T-Lymphocytes/immunology Disease Susceptibility/immunology Humans Interleukin-12/physiology Interleukin-4/physiology Leishmania major/immunology Leishmaniasis, Cutaneous/immunology Mice Mice, Inbred BALB C Protozoan Vaccines/immunology Th1 Cells/immunology Th2 Cells/immunology
Chemicals
Protozoan Vaccines Interleukin-12 Interleukin-4
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sacks David
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. dsacks@nih.gov
Noben-Trauth Nancy
Article Info
Journal
Nature reviews. Immunology
Abbr.
Nat Rev Immunol
ISSN
1474-1733
Published
2002-11-00
Pages
845-58
Language
English
Region
England
NLM ID
101124169
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com